Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Feb 2026 – 20 Aug 2026, limited by Groww Small Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Small Cap Fund | Nifty Smallcap 250 |
|---|---|---|
| 02 Feb 2026 | ₹100.00 | ₹100.00 |
| 19 Feb 2026 | ₹100.97 | ₹103.10 |
| 07 Mar 2026 | ₹98.59 | ₹99.45 |
| 24 Mar 2026 | ₹93.89 | ₹93.98 |
| 09 Apr 2026 | ₹100.72 | ₹99.98 |
| 26 Apr 2026 | ₹106.37 | ₹105.85 |
| 13 May 2026 | ₹107.94 | ₹108.23 |
| 29 May 2026 | ₹109.78 | ₹109.58 |
| 15 Jun 2026 | ₹113.16 | ₹111.51 |
| 01 Jul 2026 | ₹116.76 | ₹114.80 |
| 18 Jul 2026 | ₹118.33 | ₹116.10 |
| 03 Aug 2026 | ₹120.16 | ₹117.15 |
| 20 Aug 2026 | ₹126.00 | ₹118.26 |
| Metric | Groww · Regular NAV ₹12.63 Very High risk Unrated | Category median Small Cap Fund · 36 funds |
|---|---|---|
| — | +11.03% | |
| — | +16.76% | |
| — | +16.86% | |
| — | +16.48% | |
| +26.00% | +18.05% | |
| +73.96% | — | |
| — | +19.77% | |
| — | +19.93% | |
| — | +17.35% | |
| Risk | ||
| 18.18% | 17.13% | |
| — | 0.63 | |
| — | 0.84 | |
| -10.08% | -29.92% | |
| Nifty Smallcap 250 | — | |
| — | +0.93% | |
| — | 0.87 | |
| — | 86.6% | |
| — | 79.8% | |
| 2.75% | 2.06% | |
| ₹323.20Cr | ₹4,701Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 27% | 27% | |
| Nikhil Satam | — | |
| 02 Feb 2026 | — | |
| 51 | — | |
| 31.1% | — | |
| 12.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.